Cervical dystonia causes involuntary turning, tilting, flexion or extension of the head and neck. It is often associated with pain and may also include head tremor. Botulinum toxin treatment can selectively reduce the activity of muscles contributing to the abnormal movement pattern.
Cervical dystonia is a focal dystonia in which involuntary muscle activity causes abnormal postures or repetitive movements of the head and neck.
Some patients mainly have head rotation, while others have lateral tilt, forward flexion or backward extension. Mixed patterns are common, and similar-looking head positions may be produced by different combinations of active muscles.
These classical terms describe the direction of abnormal head and neck posture. In clinical practice, pure forms are less common than mixed patterns containing several components.
Predominant rotation of the head to one side.
Lateral tilt of the head and neck toward the shoulder.
Predominant forward flexion of the head or neck.
Predominant backward extension of the head or neck.
Botulinum toxin is one of the main treatments for focal cervical dystonia. It is injected directly into muscles contributing to the abnormal posture or movement.
The treatment temporarily reduces acetylcholine release at the neuromuscular junction, decreasing excessive activity in selected muscles.
The goal is not to make the neck as weak as possible, but to restore a better balance between muscle groups, reduce abnormal movements and pain, and improve the ability to hold and move the head more comfortably.
Head position is produced by the combined action of multiple muscles. Two patients with a similar visible rotation may have very different underlying patterns of muscle activity.
May contribute to rotation, extension and some patterns of dystonic head tremor.
Commonly contributes to rotational and mixed patterns, but should be evaluated together with other muscles.
May contribute to lateral tilt, rotation and abnormal positioning of the shoulder girdle.
Can form part of complex patterns involving both neck and shoulder position.
Deep muscles can be important in specific movement patterns and may require more precise localisation.
In most patients, the abnormal posture is produced by several muscles rather than one isolated muscle.
A detailed assessment considers not only the direction of movement, but also the anatomical level at which the movement is generated. Modern analysis distinguishes predominantly upper cervical head movement from movement of the cervical spine relative to the trunk.
The abnormal movement occurs mainly in the upper cervical segments, with the head changing position relative to the neck.
A rotational pattern at this level may be described as torticaput.
The cervical spine changes position relative to the trunk. Different muscle groups may be involved compared with a visually similar head movement.
A rotational pattern at this level corresponds to classical torticollis.
Head and neck position, direction of movement, tremor, pain, shoulder position and compensatory movements are assessed.
The muscles contributing most strongly to the abnormal movement are identified.
Botulinum toxin is distributed between selected muscles using individually determined doses.
The outcome of the previous cycle is used to refine the next treatment session.
Many superficial muscles can be identified accurately from anatomical landmarks and clinical examination. In other situations, additional guidance can help localise the target muscle more precisely.
Ultrasound allows direct visualisation of muscles and nearby structures, while EMG can help identify muscles showing abnormal activity.
In some patients, cervical dystonia includes not only an abnormal sustained posture but also dystonic head tremor.
The tremor may be irregular, become more noticeable in specific head positions and coexist with rotation or lateral tilt.
When tremor is prominent, it is particularly important to identify the muscles contributing to the oscillatory movement. The injection pattern may therefore differ from treatment of predominantly tonic dystonia.
Neck and shoulder pain is one of the most common and clinically important symptoms of cervical dystonia. For some patients, pain is the main reason for seeking neurological treatment.
Botulinum toxin treatment can reduce not only abnormal posture and movement but also dystonia-related pain. Pain relief should therefore be assessed separately when evaluating the response to treatment.
An insufficient response to previous botulinum toxin treatment does not always mean that the treatment itself is ineffective. Before abandoning the approach, it is useful to understand why the response was limited.
Dystonia can change over time, and the original injection strategy may not have addressed all components of the movement.
Visible posture alone does not always reveal the true muscles driving the dystonia.
The total dose matters, but so does the way it is distributed between individual muscles.
It is useful to know whether there was any benefit, when it began, how strong it was and how long it lasted.
In selected cases, diagnosis, injection technique, the need for guidance and uncommon causes of secondary treatment failure may also need review.
Botulinum toxin treatment for cervical dystonia is generally well tolerated. Local discomfort, a small bruise or temporary weakness of some neck muscles may occur.
Most adverse effects are temporary and gradually resolve as the effect of the medication decreases.
Botulinum toxin targets overactive muscles, but treatment of cervical dystonia does not necessarily consist of injections alone.
Depending on the clinical situation, rehabilitation may include exercises, work on head control, neck movement and everyday function. The programme should reflect the individual movement pattern rather than simply trying to force the neck out of the dystonic posture.
Dr Lidiia Prakhova, MD, PhD, is a neurologist with clinical experience in movement disorders and the use of botulinum toxin for neurological conditions.
In cervical dystonia, treatment planning begins with analysis of the movement: head and neck posture, direction of abnormal movement, tremor, pain and compensatory muscle activity.
The injection pattern is individual. Response to the previous cycle is particularly useful when planning subsequent treatment.
If you have received botulinum toxin treatment before, it is helpful to bring the product name, total dose, injected muscles and doses, date of the most recent procedure and information about the duration and degree of benefit.
Yes. For most patients with focal cervical dystonia, botulinum toxin is considered a first-line treatment.
Similar visible head positions may be produced by different combinations of active muscles. Muscle selection and dose distribution therefore need to be individualised.
Yes. Pain is common in cervical dystonia, and reducing pain is an important treatment goal.
In some patients, yes. It is particularly important to identify the muscles directly contributing to the tremor, so the injection strategy may differ from tonic dystonia.
No. Guidance may be particularly helpful for deep muscles, complex patterns or insufficient response to previous treatment, but it is not required for every injection.
Treatment is often repeated at approximately three-month intervals, although the optimal interval depends on duration of benefit and the individual clinical situation.
It may be useful to reassess the movement pattern, target muscles, dose distribution and response to the previous cycle. A limited response does not always mean that botulinum toxin is unsuitable for the patient.
If your head turns or tilts involuntarily, you have neck pain or head tremor, or previous botulinum toxin treatment provided insufficient benefit, a neurological consultation can help define the movement pattern and plan further treatment.
Book a consultation